Global Liver Institute

NASH News

GLOBAL LIVER INSTITUTE

NASH News
A Critical Time in NASH

A Critical Time in NASH

With NASH drug approval in the US on the horizon, energy has been high throughout the field. Nevertheless, we still face challenges – regulatory science must be aligned, and advocacy among stakeholders must be employed to help patients understand what to expect once we enter this new stage of NASH treatments.

read more
The Road to #NASHday: Guidelines, Roadmaps, & Actions for Today

The Road to #NASHday: Guidelines, Roadmaps, & Actions for Today

In 2021, GLI NASH Council partners collaborated to draft this set of actionable recommendations for the full spectrum of stakeholders involved in NASH prevention and treatment, including: patients and caregivers, clinicians, patient advocacy organizations, medical societies, industry…

read more
New Year, Fresh Perspectives

New Year, Fresh Perspectives

I had the opportunity to participate in the NASH-TAG 2022 Conference in Park City, Utah. Thank you to course directors Michael Charlton, MBBS, FRCP; Vlad Ratziu, MD; Stephen Harrison, MD, and Rohit Loomba, MD, MHSc for setting a standard for high-quality scientific presentations, and even higher expectation and tone for collaboration and innovative thinking…

read more